AntidiabeticDrugsIntermediatesProduction
HuatengPharmaprovidesaonestopprocessdevelopmentservicefrom concepttocommercialization.
LearnMore>>>
SGLT2Inhibitors
SGLT2inhibitorsareaclassofprescriptionmedicinesthatareFDA-approved forusewithdietandexercisetolowerbloodsugarinadultswithtype2 diabetes
CanagliflozinIntermediates
(5-Bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]methanone
CASNO1132832-75-7
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
CASNO.898566-17-1
2-[(5-bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene
CASNO1030825-20-7
2-(4-Fluorophenyl)thiophene
CASNO.58861-48-6
DapagliflozinIntermediates
4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene
CASNO1103738-29-9
Benzene,4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]-
HuatengPharma https://ushuatengscicom
CASNO461432-23-5
EmpagliflozinIntermediates
(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane
CASNO.915095-89-5
(S)-4-iodo-1-chloro-2-(4-tetrahydrofuran-3-yloxy-benzyl)-benzene CASNO915095-94-2
DPP-4Inhibitors
DPP-4inhibitors,knownasgliptins,areaclassoforaldiabeticmedications approvedbytheFoodandDrugAdministration(FDA)totreattype2diabetes mellitusinadults.
SitagliptinIntermediates
3-Trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
CASNO762240-92-6
(R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoicacid
CASNO.486460-00-8
GLP-1Agonists
GLP-1agonistsareusedtolowerbloodsugarlevelstotreatdiabetestype2by releasingmoreinsulinintothebloodstream
SemaglutideIntermediates
Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH
CASNO.1662688-20-1
tBuO-Ste-Gljavascript:void(0)-OtBu
CASNO1118767-16-0
AEEA-AEEA
CASNO1143516-05-5
HuatengPharma https://ushuatengscicom
CH2COOH-PEG2-NH2.HCl
CASNO:134979-01-4
Boc-NH-PEG2-CH2COOH
CASNO:108466-89-3
Fmoc-NH-PEG2-CH2COOH CASNO.:166108-71-0
NH2-PEG2-CH2COOH CASNO:134978-97-5
MeetUsInPerson
CPhINorthAmerica2023
25-27April,2023
PennsylvaniaConventionCenter,Philadelphia
Booth#322
RequestAMeeting
CPhIChina2023
19-21June,2023
ShanghaiNewInternationalExpoCenter
Booth#W1D08
RequestAMeeting